Medicare Enrolled

Dr. Punit Chadha, MD

Hematology & Oncology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4101 JAMES CASEY ST, Austin, TX 78745
5124472202
In practice since 2006 (19 years)
NPI: 1497778229 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chadha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chadha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chadha

Dr. Punit Chadha is a hematology & oncology specialist in Austin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chadha performed 29,698 Medicare services across 7,295 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chadha received a total of $550 from 14 pharmaceutical and/or device companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chadha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in TX $550 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,698
Medicare services
Top 29% in TX for hematology & oncology
7,295
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,563 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based) 6,250 $0 $3
Blood draw (venipuncture) 3,488 $8 $20
Complete blood count (CBC) with differential 3,212 $8 $36
Comprehensive metabolic blood panel 2,959 $10 $64
Lactate dehydrogenase (enzyme) level 1,882 $6 $31
Office visit, established patient (30-39 min) 1,648 $93 $368
Immunoglobulin level test 1,273 $9 $56
Flow cytometry, additional marker 941 $19 $180
Measurement of immunoglobulin light chains 840 $17 $60
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 607 $20 $128
Carcinoembryonic antigen (cea) protein level 544 $19 $99
Magnesium level test 543 $6 $29
Reticulated (young) platelet measurement 489 $35 $143
Beta-2 microglobulin (protein) level 421 $16 $96
Dexamethasone injection (steroid) 378 $0 $1
Iron level test 330 $6 $27
Iron binding capacity test 330 $9 $35
Ferritin level test (iron stores) 328 $13 $60
Complete blood count (CBC), automated 319 $6 $34
Microscopic examination for white blood cells with manual cell count 317 $4 $22
Office visit, established patient (20-29 min) 300 $64 $250
Protein measurement, serum 233 $10 $99
Immunologic analysis technique on serum 233 $29 $108
Immunologic analysis technique on serum (immunofixation) 232 $22 $160
Thyroid stimulating hormone (TSH) test 194 $16 $80
New patient office visit, complex (60-74 min) 185 $164 $709
Hospital follow-up visit, moderate complexity 121 $62 $247
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 117 $89 $657
Hospital follow-up visit, high complexity 113 $93 $357
PSA test (prostate cancer screening) 102 $18 $94
Nuclear medicine study from skull base to mid-thigh with ct scan 92 $1,211 $4,802
Testosterone (hormone) level, total 63 $25 $143
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 54 $20 $157
Administration of chemotherapy into vein, 1 hour or less 52 $75 $707
CT scan of abdomen and pelvis with contrast 47 $181 $1,067
Ct scan of chest with contrast 46 $50 $821
Flow cytometry technique for dna or cell analysis, first marker 38 $58 $298
Vitamin B-12 level test 37 $14 $76
Folic acid level test 37 $14 $73
Injection of additional new drug or substance into vein 37 $9 $108
Alpha-fetoprotein (afp) level, serum 36 $16 $102
Red blood count, automated test 36 $4 $23
Office visit, established patient, complex (40-54 min) 34 $142 $496
Administration of chemotherapy into vein, each additional hour 30 $11 $161
Nuclear medicine study whole body with ct scan 29 $1,227 $4,929
Infusion, normal saline solution , 1000 cc 26 $2 $19
Infusion into a vein for hydration, each additional hour 18 $9 $75
Ct scan of soft tissue of neck with contrast 16 $63 $658
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 15 $16 $100
Administration of additional new drug or substance into vein, 1 hour or less 15 $46 $344
CT scan of chest, without contrast 11 $46 $686
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
23.5% medium
76.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$550
Total received (2018-2024)
Avg $92/year across 6 years
Bottom 21% in TX for hematology & oncology
14
Companies
24
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$350 (63.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$200 (36.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$88
2023
$174
2022
$106
2021
$12
2020
$47
2018
$123

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$143
Janssen Biotech, Inc.
$120
E.R. Squibb & Sons, L.L.C.
$56
Novartis Pharmaceuticals Corporation
$44
Apellis Pharmaceuticals, Inc.
$30
Seagen Inc.
$24
Celgene Corporation
$22
PFIZER INC.
$20
Regeneron Healthcare Solutions, Inc.
$17
Abbott Laboratories
$16
EMD Serono, Inc.
$16
Genentech USA, Inc.
$16
Puma Biotechnology, Inc.
$15
Gilead Sciences, Inc.
$12
Top 3 companies account for 57.9% of total payments
Associated products mentioned in payments ›
Axium INS DRG IPG · BAVENCIO · DARZALEX · Empaveli · Fabhalta · IMBRUVICA · INTELLIS ADAPTIVESTIM · LIBTAYO · OPDIVO · OXBRYTA · PROMACTA · Perjeta · Pomalyst · TUKYSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Austin?
Compare hematology & oncology specialists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
26
Per 100K population
2.0
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chadha is a mixed practice specialist, with above-average Medicare volume (top 29% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chadha experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Chadha performed 6,250 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chadha receive payments from pharmaceutical companies?
Yes. Dr. Chadha received a total of $550 from 14 companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chadha's costs compare to other hematology & oncology specialists in Austin?
Dr. Chadha's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chadha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →